Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. GSK
GSK logo

GSK

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

GSK News

Trump Nominates Erica Schwartz as CDC Director

2d agoseekingalpha

GSK Reports Positive Phase I Trial Results for Mo-Rez Antibody-Drug Conjugate

Apr 13 2026NASDAQ.COM

GSK's Bold Move into Oncology with Five Late-Stage Trials

Apr 12 2026seekingalpha

CDC Vaccine Advisory Committee Receives New Operating Rules

Apr 10 2026seekingalpha

GSK Withdraws Approval for Wellcovorin Drug

Apr 10 2026seekingalpha

GSK Withdraws Autism Drug Application

Apr 09 2026stocktwits

Three Affordable Small-Cap Stocks That Deserve Another Look

Apr 09 2026Marketbeat

New Rules for CDC Immunization Committee Selection Released

Apr 08 2026seekingalpha

GSK's Exdensur Approved in China for Nasal Polyps Treatment

Apr 08 2026seekingalpha

GSK's Exdensur Approved in China for CRSwNP Treatment

Apr 08 2026NASDAQ.COM

Impact of Trump's Tariffs One Year Later

Apr 03 2026CNBC

Biotech Landscape Update: Regulatory Approvals and Acquisitions

Apr 03 2026NASDAQ.COM

UK and US Reach Drug Tariff Exemption Agreement

Apr 02 2026seekingalpha

GSK and Shionogi Complete ViiV Healthcare Transaction

Apr 01 2026NASDAQ.COM

Pharma Stocks Pfizer and GSK Provide Safe Investment Options Amid Market Uncertainty: Charts

Mar 30 2026Barron's

Stock Futures Edge Higher Amid Geopolitical Tensions and Energy Market Pressures

Mar 30 2026seekingalpha